M. L. Baroni

Most-cited papers

1. Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia.

   D. Sánchez-Martínez, M. L. Baroni, F. Gutiérrez-Agüera, H. Roca-Ho +16 more

   2019Blood118 citations Open access

   Semantic Scholar

   Save

2. 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo

   M. L. Baroni, D. Sánchez-Martínez, Francisco Gutierrez Aguera, Heleia Roca Ho +21 more

   2020Journal for ImmunoTherapy of Cancer69 citations Open access

   Semantic Scholar

   Save

3. A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL

   S. Zanetti, T. Velasco-Hernández, F. Gutiérrez-Agüera, V. Díaz +15 more

   2021Molecular Therapy38 citations Open access

   Semantic Scholar

   Save

4. CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity

   C. Bueno, T. Velasco-Hernández, F. Gutiérrez-Agüera, S. Zanetti +9 more

   2019Leukemia37 citations Open access

   Semantic Scholar

   Save

5. Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope

   T. Velasco-Hernández, S. Zanetti, H. Roca-Ho, F. Gutierrez-Aguera +10 more

   2020Journal for ImmunoTherapy of Cancer13 citations Open access

   Semantic Scholar

   Save

6. Bone Marrow Clonogenic Myeloid Progenitors from NPM1-Mutated AML Patients Do Not Harbor the NPM1 Mutation: Implication for the Cell-Of-Origin of NPM1+ AML

   R. Díaz de la Guardia, L. González-Silva, B. López‐Millán, J. J. Rodríguez-Sevilla +8 more

   2020Genes3 citations Open access

   Semantic Scholar

   Save